| 4-Hydroxytestosterone | |
|---|---|
|
4,17-Dihydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-3-one |
|
|
Other names
4,17β-Dihydroxy-4-androstene-3-one; (17β)-4,17-dihydroxyandrost-4-en-3-one |
|
| Identifiers | |
| CAS number | 2141-17-5 |
| PubChem | 160615 |
| ChemSpider | 141138 |
| DrugBank | DB01485 |
| Jmol-3D images | Image 1 |
|
|
|
|
| Properties | |
| Molecular formula | C19H28O3 |
| Molar mass | 304.42 g/mol |
| (verify) (what is: /?) Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) |
|
| Infobox references | |
4-Hydroxytestosterone (4-OHT or 4,17beta-dihydroxy-4-androstene-3-one) is an anabolic steroid. It was first patented by G.D. Searle & Company in 1955 and is testosterone with a hydroxy group at the four position. 4-OHT has moderate anabolic, mild androgenic, and anti-aromatic properties and is similar to the steroid clostebol.